White Paper | Regulatory and Manufacturing Pathways to Expand Access to Genetically Modified Cell Based Therapies | May 8, 2025 Share
White Paper | Innovative Validation And Regulatory Processes For Companion Diagnostic Tests For Rare Biomarkers Or Indications | January 28, 2025 Share
Discussion Document | Considerations For Developing Reference Data Sets For Digital Pathology Biomarkers | January 28, 2025 Share
White Paper | Enhancing Study Designs and Interpretation of Interim Overall Survival Data in Oncology Trial | November 9, 2024 Share
White Paper | Framework for Integrating Change in ctDNA Levels in Advanced Cancer Clinical Trials to Support Meta-analyses for Intermediate Endpoint Validation | November 9, 2024 Share
White Paper | Improving Equity in Oncology Clinical Trials: Challenges and Strategies for Setting Diversity Enrollment Goals | February 14, 2024 Share
White Paper | 2023 Annual Meeting | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials | November 14, 2023 Share
White Paper | 2023 Annual Meeting | Maximizing Data from Academic-Led Studies for Regulatory Decision-Making | November 14, 2023 Share
White Paper | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials | November 14, 2023 Share
